Patrick Jedlowski

1.2k total citations
34 papers, 788 citations indexed

About

Patrick Jedlowski is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Patrick Jedlowski has authored 34 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Hematology. Recurrent topics in Patrick Jedlowski's work include Multiple Myeloma Research and Treatments (11 papers), Drug-Induced Adverse Reactions (9 papers) and Protein Degradation and Inhibitors (8 papers). Patrick Jedlowski is often cited by papers focused on Multiple Myeloma Research and Treatments (11 papers), Drug-Induced Adverse Reactions (9 papers) and Protein Degradation and Inhibitors (8 papers). Patrick Jedlowski collaborates with scholars based in United States and Germany. Patrick Jedlowski's co-authors include A. Keith Stewart, Laura A. Bruins, Esteban Braggio, Yuan Xiao Zhu, K. Martin Kortüm, P. Leif Bergsagel, Chang-Xin Shi, Moulun Luo, Maryam T. Fazel and K. Martin Kortuem and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Patrick Jedlowski

32 papers receiving 781 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Jedlowski United States 13 523 432 232 77 63 34 788
Anand Jillella United States 12 456 0.9× 379 0.9× 166 0.7× 59 0.8× 15 0.2× 48 841
Joanne I. Hsu United States 7 346 0.7× 255 0.6× 87 0.4× 34 0.4× 34 0.5× 15 630
Ludo M. Evers Netherlands 8 372 0.7× 144 0.3× 126 0.5× 67 0.9× 88 1.4× 9 706
Trinayan Kashyap United States 19 756 1.4× 342 0.8× 234 1.0× 35 0.5× 5 0.1× 57 934
Maja Ludvigsen Denmark 13 219 0.4× 90 0.2× 158 0.7× 174 2.3× 18 0.3× 59 546
Cecilia Kelly United States 2 651 1.2× 77 0.2× 249 1.1× 154 2.0× 205 3.3× 4 879
Anniina Virtanen Finland 10 125 0.2× 98 0.2× 250 1.1× 66 0.9× 49 0.8× 17 570
Juuli Raivola Finland 9 117 0.2× 85 0.2× 234 1.0× 53 0.7× 38 0.6× 13 502
Gökben Baskaynak Germany 9 169 0.3× 207 0.5× 145 0.6× 39 0.5× 18 0.3× 14 464
Tatsuo Abe Japan 14 339 0.6× 125 0.3× 119 0.5× 89 1.2× 22 0.3× 26 660

Countries citing papers authored by Patrick Jedlowski

Since Specialization
Citations

This map shows the geographic impact of Patrick Jedlowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Jedlowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Jedlowski more than expected).

Fields of papers citing papers by Patrick Jedlowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Jedlowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Jedlowski. The network helps show where Patrick Jedlowski may publish in the future.

Co-authorship network of co-authors of Patrick Jedlowski

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Jedlowski. A scholar is included among the top collaborators of Patrick Jedlowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Jedlowski. Patrick Jedlowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Jedlowski, Patrick, et al.. (2023). Use of fractionated laser therapy for the treatment of androgenetic alopecia: a systematic review and meta-analysis. Lasers in Medical Science. 39(1). 4–4. 7 indexed citations
5.
6.
7.
Jedlowski, Patrick, et al.. (2021). Coronavirus disease 2019‐associated immunoglobulin A vasculitis/Henoch–Schönlein purpura: A case report and review. The Journal of Dermatology. 49(1). 190–196. 23 indexed citations
8.
Jedlowski, Patrick, et al.. (2021). DPP-4 Inhibitors and Increased Reporting Odds of Bullous Pemphigoid: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS) from 2006 to 2020. American Journal of Clinical Dermatology. 22(6). 891–900. 32 indexed citations
9.
Jedlowski, Patrick, et al.. (2020). Punctate porokeratosis—pruritic and hyperkeratotic papules on the palms and feet. Baylor University Medical Center Proceedings. 33(3). 415–416. 5 indexed citations
10.
11.
12.
Jedlowski, Patrick, et al.. (2018). Cutaneous Adverse Effects of Diabetes Mellitus Medications and Medical Devices: A Review. American Journal of Clinical Dermatology. 20(1). 97–114. 20 indexed citations
13.
Shi, Chang-Xin, K. Martin Kortüm, Yuan Xiao Zhu, et al.. (2017). CRISPR Genome-Wide Screening Identifies Dependence on the Proteasome Subunit PSMC6 for Bortezomib Sensitivity in Multiple Myeloma. Molecular Cancer Therapeutics. 16(12). 2862–2870. 42 indexed citations
14.
Zhu, Yuan Xiao, Chang-Xin Shi, Laura A. Bruins, et al.. (2017). Loss of FAM46C Promotes Cell Survival in Myeloma. Cancer Research. 77(16). 4317–4327. 53 indexed citations
15.
Fazel, Maryam T., et al.. (2017). Evaluation and Treatment of Acute and Subacute Hearing Loss: A Review of Pharmacotherapy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 37(12). 1600–1616. 5 indexed citations
16.
Kortuem, K. Martin, Esteban Braggio, Laura A. Bruins, et al.. (2016). Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients. Blood Cancer Journal. 6(2). e397–e397. 32 indexed citations
17.
Kortüm, K. Martin, Yuan Xiao Zhu, Chao Shi, Patrick Jedlowski, & A. Keith Stewart. (2015). Cereblon binding molecules in multiple myeloma. Blood Reviews. 29(5). 329–334. 40 indexed citations
18.
Kortüm, K. Martin, Christian Langer, Jorge Monge, et al.. (2015). Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M3P). Annals of Hematology. 94(7). 1205–1211. 36 indexed citations
19.
Jedlowski, Patrick, et al.. (2015). Identification of FAM46C as a tumor suppressor in multiple myeloma. Clinical Lymphoma Myeloma & Leukemia. 15. e64–e64. 1 indexed citations
20.
Zhu, Yuan Xiao, Hongwei Yin, Laura A. Bruins, et al.. (2014). RNA interference screening identifies lenalidomide sensitizers in multiple myeloma, including RSK2. Blood. 125(3). 483–491. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anand Jillella Breakdown of academic impact, for papers by Joanne I. Hsu Breakdown of academic impact, for papers by Ludo M. Evers Breakdown of academic impact, for papers by Trinayan Kashyap Breakdown of academic impact, for papers by Maja Ludvigsen Breakdown of academic impact, for papers by Cecilia Kelly Breakdown of academic impact, for papers by Anniina Virtanen Breakdown of academic impact, for papers by Juuli Raivola Breakdown of academic impact, for papers by Gökben Baskaynak Breakdown of academic impact, for papers by Tatsuo Abe
Rankless by CCL
2026